BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2052 related articles for article (PubMed ID: 18805066)

  • 1. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up.
    Guyer RD; McAfee PC; Banco RJ; Bitan FD; Cappuccino A; Geisler FH; Hochschuler SH; Holt RT; Jenis LG; Majd ME; Regan JJ; Tromanhauser SG; Wong DC; Blumenthal SL
    Spine J; 2009 May; 9(5):374-86. PubMed ID: 18805066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part II: evaluation of radiographic outcomes and correlation of surgical technique accuracy with clinical outcomes.
    McAfee PC; Cunningham B; Holsapple G; Adams K; Blumenthal S; Guyer RD; Dmietriev A; Maxwell JH; Regan JJ; Isaza J
    Spine (Phila Pa 1976); 2005 Jul; 30(14):1576-83; discussion E388-90. PubMed ID: 16025025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomized study of the Charite artificial disc: data from two investigational centers.
    Guyer RD; McAfee PC; Hochschuler SH; Blumenthal SL; Fedder IL; Ohnmeiss DD; Cunningham BW
    Spine J; 2004; 4(6 Suppl):252S-259S. PubMed ID: 15541674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lumbar disc arthroplasty with Maverick disc versus stand-alone interbody fusion: a prospective, randomized, controlled, multicenter investigational device exemption trial.
    Gornet MF; Burkus JK; Dryer RF; Peloza JH
    Spine (Phila Pa 1976); 2011 Dec; 36(25):E1600-11. PubMed ID: 21415812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized, multicenter Food and Drug Administration investigational device exemptions study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: part I: evaluation of clinical outcomes.
    Blumenthal S; McAfee PC; Guyer RD; Hochschuler SH; Geisler FH; Holt RT; Garcia R; Regan JJ; Ohnmeiss DD
    Spine (Phila Pa 1976); 2005 Jul; 30(14):1565-75; discussion E387-91. PubMed ID: 16025024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, randomized trial of metal-on-metal artificial lumbar disc replacement: initial results for treatment of discogenic pain.
    Sasso RC; Foulk DM; Hahn M
    Spine (Phila Pa 1976); 2008 Jan; 33(2):123-31. PubMed ID: 18197095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of the prospective, randomized, controlled multicenter Food and Drug Administration investigational device exemption study of the ProDisc-C total disc replacement versus anterior discectomy and fusion for the treatment of 1-level symptomatic cervical disc disease.
    Murrey D; Janssen M; Delamarter R; Goldstein J; Zigler J; Tay B; Darden B
    Spine J; 2009 Apr; 9(4):275-86. PubMed ID: 18774751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial disc versus fusion: a prospective, randomized study with 2-year follow-up on 99 patients.
    Sasso RC; Smucker JD; Hacker RJ; Heller JG
    Spine (Phila Pa 1976); 2007 Dec; 32(26):2933-40; discussion 2941-2. PubMed ID: 18091483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological complications of lumbar artificial disc replacement and comparison of clinical results with those related to lumbar arthrodesis in the literature: results of a multicenter, prospective, randomized investigational device exemption study of Charité intervertebral disc. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004.
    Geisler FH; Blumenthal SL; Guyer RD; McAfee PC; Regan JJ; Johnson JP; Mullin B
    J Neurosurg Spine; 2004 Sep; 1(2):143-54. PubMed ID: 15346999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease.
    Zigler J; Delamarter R; Spivak JM; Linovitz RJ; Danielson GO; Haider TT; Cammisa F; Zuchermann J; Balderston R; Kitchel S; Foley K; Watkins R; Bradford D; Yue J; Yuan H; Herkowitz H; Geiger D; Bendo J; Peppers T; Sachs B; Girardi F; Kropf M; Goldstein J
    Spine (Phila Pa 1976); 2007 May; 32(11):1155-62; discussion 1163. PubMed ID: 17495770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MOS short form 36 and Oswestry Disability Index outcomes in lumbar fusion: a multicenter experience.
    Glassman S; Gornet MF; Branch C; Polly D; Peloza J; Schwender JD; Carreon L
    Spine J; 2006; 6(1):21-6. PubMed ID: 16413443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ProDisc artificial total lumbar disc replacement: introduction and early results from the United States clinical trial.
    Delamarter RB; Fribourg DM; Kanim LE; Bae H
    Spine (Phila Pa 1976); 2003 Oct; 28(20):S167-75. PubMed ID: 14560188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement compared with circumferential arthrodesis for the treatment of two-level lumbar degenerative disc disease: results at twenty-four months.
    Delamarter R; Zigler JE; Balderston RA; Cammisa FP; Goldstein JA; Spivak JM
    J Bone Joint Surg Am; 2011 Apr; 93(8):705-15. PubMed ID: 21398574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient selection for lumbar arthroplasty and arthrodesis: the effect of revision surgery in a controlled, multicenter, randomized study.
    Geisler FH; Guyer RD; Blumenthal SL; McAfee PC; Cappuccino A; Bitan F; Regan JJ
    J Neurosurg Spine; 2008 Jan; 8(1):13-6. PubMed ID: 18173341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access strategies for revision or explantation of the Charité lumbar artificial disc replacement.
    Wagner WH; Regan JJ; Leary SP; Lanman TH; Johnson JP; Rao RK; Cossman DV
    J Vasc Surg; 2006 Dec; 44(6):1266-72. PubMed ID: 17145428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomechanical evaluation of total disc replacement arthroplasty: an in vitro human cadaveric model.
    Cunningham BW; Gordon JD; Dmitriev AE; Hu N; McAfee PC
    Spine (Phila Pa 1976); 2003 Oct; 28(20):S110-7. PubMed ID: 14560182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lumbar disc arthroplasty versus anterior lumbar interbody fusion: 5-year outcomes for patients in the Maverick disc investigational device exemption study.
    Gornet MF; Burkus JK; Dryer RF; Peloza JH; Schranck FW; Copay AG
    J Neurosurg Spine; 2019 May; 31(3):347-356. PubMed ID: 31100723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized, controlled clinical investigation comparing PCM cervical disc arthroplasty with anterior cervical discectomy and fusion. 2-year results from the US FDA IDE clinical trial.
    Phillips FM; Lee JY; Geisler FH; Cappuccino A; Chaput CD; DeVine JG; Reah C; Gilder KM; Howell KM; McAfee PC
    Spine (Phila Pa 1976); 2013 Jul; 38(15):E907-18. PubMed ID: 23591659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ProDisc-C and anterior cervical discectomy and fusion as surgical treatment for single-level cervical symptomatic degenerative disc disease: five-year results of a Food and Drug Administration study.
    Zigler JE; Delamarter R; Murrey D; Spivak J; Janssen M
    Spine (Phila Pa 1976); 2013 Feb; 38(3):203-9. PubMed ID: 23080427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lumbar spine arthroplasty using the ProDisc II.
    Zigler JE
    Spine J; 2004; 4(6 Suppl):260S-267S. PubMed ID: 15541675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 103.